No university or nonprofit has that kind of budget, and even if they did, they are unlikely to take on the risk of a failed drug.
No university or nonprofit has that kind of budget, and even if they did, they are unlikely to take on the risk of a failed drug.
Marketing spend is based on the idea you spend $X and get $X + Y back. This doesn't always work, but it's the general premise.
This means without marketing dollars they'd be making less money.
Drugs are things that people "need". If no drug companies advertised, people would still go to their doctors with problems, and doctors would still prescribe medication when necessary (you have some degree of advertising prompting doctor visits, but for the important stuff, and in a system where people are not afraid of the monetary cost of going to a doctor, they'll be going anyway).
However currently all drug manufacturers must advertise their products because their competitors advertise their competing products. Anyone who doesn't advertise will be left behind as patients request the drug that they saw on TV. No company wants to be the company that doesn't advertise.
Advertising makes advertising necessary. It's a sort of "Advertising Prisoners Dilemma": http://en.wikipedia.org/wiki/Prisoner's_dilemma#In_economics
One way to break this is to create laws that forbid advertising. Another is to allow the formation of cartels.
However, the cost of human trials are still a problem. Because of the costs, drug research to treat rare diseases aren't going to get funded by anyone.
So you're saying that drug advertising is pulling the wool over the eyes of the entire industry so that they give patients nothing more than placebos?
Most drugs, even those that offer a benefit over current therapies, don't sell themselves. Physicians need to learn about new drugs, have an opportunity to try them before you ever see widespread use.
For instance, with patents there is an incentive to find a solution first. This probably raises the cost of research because (a) pharmas spend more time researching alternative medicines with different compounds with the same effect as existing drugs simply to get around pre-existing patents and (b) pharmas spend more money to rush research to patent it first.
Also, if clinical trials are the problem, India appears to be willing to help.